Nevertheless, our observation of the loss of correlation between serum hepcidin and iron levels in AD patients suggest that iron dyshomeostasis in AD patients may extend beyond alterations in serum levels into a disruption of hepcidin regulatory control. This evidence concerns the gene HAMP and Alzheimer disease.